Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ciprofol plus sufentanil dose-finding for laryngeal mask placement during hysteroscopy
ChiCTR2300068598Phase 4Not yet recruiting
- Sponsor
- Guangdong Second Provincial General Hospital
- Start
- Feb 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of ciprofol and sufentanil, sponsored by Guangdong Second Provincial General Hospital. Primary endpoint: Satisfactory laryngeal mask placement. Planned start Feb 2023; status: not yet recruiting.
02
Drugs
ciprofolsufentanil
Beyond the preview
Go deeper on ChiCTR2300068598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300068598.